The ERK/MAPK pathway, with the upstream receptors and downstream regulatory elements, appeared in the enrichment results, indicating that ERK pathway provides a significant way for PCF to exert therapeutic effect on MI with depression. This evidence concerns the gene MAPK1 and depressive symptom measurement.